Self-regulation of autologous cell therapies

Bernard E. Tuch, Dominic M. Wall

    Research output: Contribution to journalComment / DebateOtherpeer-review

    9 Citations (Scopus)


    A first step for a virtually unregulated industry Autologous cell therapies are being used privately by increasing numbers of clinicians to treat a number of disorders including rheumatological conditions, sports injuries, strokes, Parkinson disease and multiple sclerosis. Sources of cells include stromal vascular fractions obtained during liposuction which contain mesenchymal stem cells, as well as platelet rich plasma obtained from peripheral blood.

    Original languageEnglish
    Pages (from-to)196
    Number of pages1
    JournalThe Medical Journal of Australia
    Issue number4
    Publication statusPublished - 3 Mar 2014

    Cite this